COVID-19 vaccine ‘Covaxin’ marks a significant milestone: Karnataka Health Minister

▴ COVID-19 vaccine ‘Covaxin’ marks a significant milestone: Karnataka Health Minister
Karnataka Minister for Health and Medical Education Dr. K. Sudhakar has come forward to negate suspicion on the Covaxin vaccine developed by Bharat Biotech.

Karnataka Minister for Health and Medical Education Dr. K. Sudhakar has come forward to negate suspicion on the Covaxin vaccine developed by Bharat Biotech.

He has appeared as a fellow medical professional to refrain from unwarranted criticism discrediting the hard work of the scientists involved in the development of the vaccine within the country.
 
In a series of tweets today, the Minister said that the COVID-19 vaccine Covaxin developed within the country marks a significant milestone. He said that India being one of the largest exporters of vaccines and the world is looking up to India in the common fight against the global pandemic.

The Minister stressed that Bharat Biotech is a globally reputed company with the credibility and experience of developing 16 vaccines including for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika, and the world’s first tetanus-toxoid conjugated vaccine for Typhoid.

 
Dr. Sudhakar informed that Bharat Biotech has delivered over four billion vaccine doses to the underprivileged people in more than 150 developing countries through UNICEF and other channels.

On the clinical trials of Covaxin, the Minister said, the Phase-3 clinical trial involves 24,000 volunteers and its data will be available soon

Tags : #KarnatakasCovid-19Update05Jan2021 #Karnataka #India #HealthandEducationMinister #DrKSudhakar #Covid-19Vaccine #BharatBiotech #Covaxin #VaccineForCovidTreatment #VaccineClinicalTrails #FightAgainstCovidVirus

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024